Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients

NCT02424773 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT02424773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02424773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2012
Completion date
April 30, 2015
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, high flow oxygen cannula, immunocompromised host